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W
ith very little fanfare, 
American science will make 
a sizeable leap forward 
in the coming year—if Congress 
and the National Institutes of 
Health deliver on their promise for 
public access to medical research. 
As scientists—one of us a Nobel 
researcher in biomedical science 
and one of us a recently tenured 
faculty member at the Massachusetts 
Institute of Technology—we may have 
much to celebrate for scientists of all 
generations. 
As scientists, scientiﬁ  c literature is 
our lifeblood, because only by reading 
our colleagues’ work can we know 
where the cutting edge of knowledge 
currently lies and hence where our 
work should be directed. 
Yet increasingly, subscriptions to 
the very journals that we must read are 
becoming too expensive—often in the 
thousands of dollars. The availability of 
the information vital to our research is 
needlessly restricted by the publishers of 
the scientiﬁ  c literature, who are mainly 
large commercial entities for whom 
maximizing proﬁ  ts is their priority. 
Fortunately, help is at hand. The big “if” 
remains whether this will happen. 
The National Institutes of Health 
have championed their wish to 
maintain all federally funded medical 
research in a publicly accessible online 
archive maintained by the National 
Library of Medicine’s PubMed Central. 
It stands to reason that taxpayer-
supported science should be available 
to all. The Pew Trust recently reported 
that 93 million Americans searched for 
medical knowledge on the Web to ﬁ  nd 
the latest information for their health 
conditions, and more importantly, 58% 
actually took this information to their 
doctors. The public interest is clear. 
What about the interests of science? 
We know ﬁ  rsthand that faster, barrier-
free access to scientiﬁ  c research 
ﬁ  ndings is equally good if not more 
compelling for science and scientists—
senior and early-career researchers 
alike. It’s good for science because 
knowledge is cumulative—it advances 
by building on previous knowledge. 
Research in a vacuum has little or no 
value; it is inﬁ  nitely more valuable 
when shared and used. 
Let’s also be plain about the 
advancement of scientists, not just 
good science. When barriers to access 
are swept away, research is used more, 
and that equates to more citations. 
Scientiﬁ  c peers acknowledge our 
work more frequently, and as we all 
acknowledge, citations are the coin 
of the realm in all scientiﬁ  c ﬁ  elds. 
Citations demonstrate the signiﬁ  cance 
of a scientist’s research and thus 
advance our careers as well as our 
work itself. 
For younger scientists, being 
recognized is critical to our 
professional successes. Making our 
work openly available is a means of 
being recognized and emulated. 
Senior researchers also should be 
encouraging their graduate students 
and postdoctoral colleagues to use 
open access for career advancement. 
Even if the prestigious journals 
in our ﬁ  elds are not yet open 
access, young scientists always have 
opportunities to make our work 
available in an open archive like 
PubMed Central or at our universities’ 
online institutional repositories.  
Academic institutions and the science 
community are forging new, innovative 
partnerships to advance science and to 
promote the best minds by harnessing 
an open-access environment. 
For those of us who have dedicated 
our lives to science, public access is 
a two-way street. We can more easily 
read other scientists’ works (which 
helps our research), and they can 
read ours (making it far more likely 
to be cited). Younger researchers, 
educated and raised in the networked 
digital environment, are used to 
moving seamlessly from info source 
to info source. The scientiﬁ  c research 
environment should respond to and 
favor this effective work style. 
Knowledge itself is seamless, as ideas 
spark other ideas, or reject unworkable 
ones. Through public access to science, 
at last we will have the advantage of 
being able to move from primary 
literature to other data sources—
and back. Finally, we will have the 
opportunity within our grasp to follow 
a research thread in the ideal way, 
without artiﬁ  cial barriers, gaps, and 
tariffs, regardless of the type of material 
or who owns and curates it—and to 
instantly make connections. In an age 
rife with the potential for infectious 
pandemics, bioterrorism, and toxic 
environmental calamity, and at a time 
when we need new ways to cure terrible 
illnesses, public access is our society’s 
compelling answer to accelerating the 
best science possible. This advance 
is much needed, both by researchers 
working in academic settings and in 
the private sector. Indeed, we should 
demand no less. We invite our fellow 
scientists to join in the demand for 
open access to biomedical literature.  
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